1 History of filariasis
=======================

1.1 Scientific discovery
------------------------

Early scientific milestones in filariasis history abroad include the following.

1.  1863: Demarquay in Paris found microfilariae in hydrocele liquid of a Cuban.

2.  1866: Wucherer found microfilariae in chyluria.

3.  1872: Lewis found microfilariae in blood.

4.  1877: Bancroft found a female adult filarial worm in the ulcer of lymph node of the arm.

5.  1877: Manson found microfilariae in the stomach of bloodsucked mosquito, which was practically the "birth" of medical entomology.

6.  1879: Manson found microfilarial nocturnal periodicity.

7.  1888: Sibthorpe found male adult worms.

Those in Japan include the following.

1.  1876: Erwin Von Baelz detected microfilariae in blood (in Tokyo).

2.  1896: Yushitaro Matsuura found a female adult worm in an inguinal lymph node (in Kumamoto).

3.  1903: Shichiro Hida found a male filaria in the left seminiferous hydrocele.

1.2 Ancient filariasis
----------------------

About 600 B.C., a singular symptom of bancroftian filariasis (elephantiasis arabum) was described by ancient Hindus and Persian doctors. However, there is an indication that lymphatic filariasis existed as early as 1500 B.C. The funeral temple of Queen Hatshepsut (1501-1480 B.C.) is located at the foot of a mountain that commands a fine view in Thebes (now Luxor city), Egypt. To the back (north) of the mountain is the Valley of the Kings where the tomb of Tutankhamen was found. Replicas of illustrations possibly depicting elephantiasis can be seen on the right side second layer limestone wall of the funeral temple along the middle terrace (Fig. [1](#F1){ref-type="fig"}a). The original reliefs have been exhibited at the Egyptian Museum in Cairo (Fig. [1](#F1){ref-type="fig"}b), with the following explanation: 'Very fine painted limestone reliefs from Terrace of Queen Hatshepsut's temple at EL-Deir Bahari which record a trading expedition to Punt, a locality near the sea and South of Egypt. The center block depicts the prince of Punt and his wife, the latter obviously suffering from *elephantiasis* (Fig. [1](#F1){ref-type="fig"}d), followed by bearers of merchandise. On the left is the princess' ass, above which is inscribed "the ass which carries his wife"' (Fig. [1](#F1){ref-type="fig"}c).

In Japan, pictures of a female with elephantiasis-like lower extremities and a male with suspected hydrocele/elephantiasis of the scrotum, which date back to about A.D. 1100-1200, were found. One picture in the "Diseases Picture Scroll", which is the property of Tokyo National Museum, depicts a female with possible elephantiasis of the legs (Fig. [2](#F2){ref-type="fig"}a, b, c, d). The pictures in the "Strange Diseases Picture Scroll", which is the property of Kyoto National Museum, show leg elephantiasis and hydrocele/elephantiasis of the scrotum (Fig. [3](#F3){ref-type="fig"}a, b, c, d).

Concerning a big scrotum, the "Unofficial History of Kuma" describes an episode of a young soldier named Yohyoe Kitazaki. During the war between the Satsuma (Kagoshima) and Sagara (Kumamoto) clans fought in 1555, Kitazaki showed his comrades a wrapped head of a Satsuma enemy, which indicated his war achievement. In fact, however, in the cloth wrapper was a hydrocele of human-head size cut off from a dead soldier. The story suggests that a huge hydrocele was not uncommon in Satsuma in those days. Hokusai Katsushika (1760-1849), a renowned Japanese artist, portrayed huge elephantiasis of the scrotum in paintings (Fig. [4](#F4){ref-type="fig"}).

2 Epidemiology and control of filariasis
========================================

2.1 Prevalence in Kagoshima prefecture
--------------------------------------

Between 1911 and 1961, a year before the government-sponsored National Filariasis Control Program was started, there were 176 published reports on filariasis. The reported endemicity in mainland Kagoshima and coastal islands is shown in Table [1](#T1){ref-type="table"}a, b. The microfilaria positive rate among people living on coastal islands was 16.6% (4,337 positives out of 26,069 examined), and the rate was especially high in Amami Oshima Island at 19.6%. In mainland Kagoshima, the microfilaria positive rate was 11.3% (1,629 positives out of 14,359 examined), revealing that filariasis was widely spread in Kagoshima prefecture.

2.2 Filariasis treatment with diethylcarbamazine
------------------------------------------------

For filariasis treatment, antimonials or arsenicals had been used without satisfactory results. In 1947, Hewitt and his colleagues used one of the piperazine derivatives, 1-diethyl-carbamyl-4-methylpiperazine hydrochloride (Hetrazan), for the first time and reported that it showed remarkable effects in the treatment of *Litomosoides carinii and Dirqfilaria immitis*. Afterwards, Santiago-Stevenson *et al.* (1947), Hewitt *et al.* (1950), and others reported, one after another, the disappearance of microfilariae in blood by using the drug. In Japan, Suganuma (Department of Pharmacology, Tokyo University, 1950) synthesized 1-diethylcarbamyl-4-methyl-piperazine citrate (Supatonin). Notable anti-microfilarial effects of Supatonin were confirmed and reported by such famous researchers as Kitamura and Katamine (1951), Sasa and Hayashi (1951), and Hachiro Sato (1952).

The drug, Supatonin, came into our possession in 1950 for trial use, and was proven to exert remarkable effects in filariasis control programs.

Kiyohara district, Bonotsu, Kagoshima prefecture, was heavily affected with filariasis and there were many symptomatic cases. Different doses of diethylcarbamazine citrate (DEC) were tested in the district and anti-microfilarial effects were followed up for as long as 5 years (Fig. [5](#F5){ref-type="fig"}). The study revealed that DEC was most effective when administered at a total dose of 71 mg/kg of body weight (BW). As the efficacy persisted for 5 years, it was considered that the dose could affect not only microfilariae but also adult worms.

2.3 Basic issues considered in conducting filariasis surveys
------------------------------------------------------------

In the early stage of filariasis studies when a large-scale treatment campaign was expected in the near future, it was necessary to answer several basic questions, such as i) suitable treatment scheme (optimal dose of DEC and treatment period), ii) occurrence of side reactions after treatment, iii) suitable time for blood sampling, iv) amount of blood to be used for microfilaria detection, v) capability of examiners to collect blood samples, and vi) how to secure people's cooperation.

### (1) Treatment scheme:

The same dose of 5 mg/kg BW was given in 3 different treatment schedules, that is, 5 mg/kg daily for 10 days, once a week for 10 weeks, and once a month for 10 months. The study revealed that there was no difference among the 3 schedules (microfilaria reduction 74-80% at 1 year). Results of a 10-year follow-up study on the effect of 10 weekly treatments at 5 mg/kg, followed by another treatment at 6 mg/kg x 5 times 1 year after the weekly treatments, are shown in Fig. [6](#F6){ref-type="fig"}.

### (2) Occurrence of side reactions after treatment:

A variety of side effects developed after DEC administration, especially in microfilaria positive persons (Table [2](#T2){ref-type="table"}). The most problematic one was fever, which occurred in 25.9% of those treated. The fever appeared 1-3 days after the start of DEC administration in most cases, and became highest when microfilariae decreased rapidly in blood (Fig. [7](#F7){ref-type="fig"}). The fever lowered gradually even when the drug was taken continuously. It has been assumed that fever is the result of allergic or pyrogenic reaction caused by killed worms. In the case of *Brugia malayi* high fever is common, while in *Wuchereria bancrofti* it is around 37.0°C. People used to accept the explanation that they should continue taking DEC even when fever appeared, because the fever was a sign that the drug was killing parasites.

### (3) Suitable time for blood sampling:

Nocturnally periodic *W. bancrofti* was endemic in Japan. In order to decide the proper time for blood collection, 63 known microfilaria positives were examined at 18:00, 19:00, 20:00, 21:00, and 22:00 hours, and microfilaria rates and counts were compared (Table [3](#T3){ref-type="table"}). At 21:00, the count was only about a half of that at 22:00. However microfilaria detection rate was 98.4% (100% at 22:00). It was concluded that sampling at 21:00 was acceptable as long as careful microscopical examination would be done. Another factor necessary to decide sampling time was the relationship with people. People were requested to gather at a public hall for blood collection, and expected to be examined as early as possible. Considering the fact that a usual sample collection needed 3 to 4 hours to complete, the start at 21:00 was considered reasonable.

### (4) Amount of blood to be used for microfilaria detection:

Different quantities of 10 µl (sample A), 20 µl (sample B), and 30 µl (sample C) were smeared on each slide glass to compare the efficiency of microfilaria detection (60 µl in total was collected from each person). With 76 microfilaria positive persons, the positive rates according to different blood quantity were 66/76 (86.8%) in (A), 72/76 (94.7%) in (B), 74/76 (97.4%) in (A+B, 30 µl of blood), 73/76 (96.1%) in (C), and 76/76 (100%) in (A+B+C, 60 µl of blood). The total number of microfilariae detected was 579, 982, 1561, 1277 and 2838, respectively, which are in the ratios of 1 : 1.7 : 2.7 : 2.2 : 4.9. Although collecting 60 µl of blood was ideal, it was decided to use 30 µl samples.

### (5) Capability of examiners to collect blood samples:

After a few days of training, an examiner became efficient enough to process about 100 blood smears in 3 hours, from 21:00 to 24:00 hours.

### (6) How to secure people's cooperation:

It became apparent that the most important and effective strategy to control filariasis was to obtain the support of people. At the same time, it was understood, by a questionnaire-based survey, that people did not have sufficient knowledge on filariasis transmission and its control. The survey revealed that 87 (25.1%) of 346 people questioned gave the answer that filariasis was a hereditary disease. Only about a half (52.8%) of those questioned knew that filariasis was an infectious disease. As for the night blood survey, 72 people (20.8%) answered that the survey was conducted at night for the convenience for the people gathering, while 230 (66.4%) correctly related it to the nocturnal periodicity of microfilariae. Activities to enlighten people were then intensified both by academic institutions and administrative agencies. Circulars explaining the importance of mosquitoes as a vector, and the necessity of blood examinations and DEC treatment were distributed. In villages, live microfilariae were demonstrated using a microscope.

In conclusion, the following policies were proposed for filariasis surveys: i) 30 µl of blood is taken starting from 21:00 hours, ii) one examiner collects 100 blood samples per night, iii) DEC is given at 70 mg/kg BW in total, which can be administered continuously (daily) or intermittently (weekly or monthly), and iv) to secure people's cooperation, publicity and education activities are essential. Thorough explanation is needed on side reactions, especially fever.

2.4 The National Filariasis Control Program
-------------------------------------------

After the end of World War II, such leading researchers as Hachiro Sato (Kagoshima University), Daisuke Katamine (Nagasaki University) and Manabu Sasa (Tokyo University) clarified the situation of filariasis prevalence in Japan. The disease was spread widely, affecting many people. The researchers urged the government to establish a national project to control filariasis, and the National Filariasis Control Program was inaugurated in 1962. The program continued for 10 years until l971.

The filariasis control measures included two components: anti-vector mosquito activities (residual spraying of DDT) and treatment of microfilaria carriers. However, it became apparent that the two components could not be performed together particularly in remote areas and islands. Accordingly, an emphasis was put on detecting microfilaria positives by night blood survey and treating them with DEC. The standard treatment recommended by the Ministry of Health was as follows. Using a 50 mg DEC tablet, adults are given 2 tablets/day for 3 consecutive days, 6 tablets/day for the next 3 days, followed by weekly dose of 6 tablets/day for 8 weeks. Thus 9 weeks were needed to complete the treatment. For younger people, reduced dosages were used but with the same time schedule, that is, for junior high school students, 2 tablets/day in the first 3 days and 4 tablets/day thereafter, and for elementary school and younger children, 1 tablet/day first and then 3 tablets/day.

Nine local governments (Tokyo and 8 prefectures) participated in the National Filariasis Control Program for 10 years (1962-1971), during which time 2,039,728 people were examined and 27,450 (l.7%) microfilaria positives were found. Particularly in Kagoshima prefecture, as many as 27,450 (3.56%) positives were found among 771,924 people examined, and in Nagasaki prefecture, 6,214 (0.88%) out of 709,300 were positive. The known microfilaria positive persons were treated with DEC with remarkable success. Yearly changes in microfilaremia prevalence in Kagoshima prefecture are shown in Table [4](#T4){ref-type="table"}.

2.5 Follow-up studies by means of the nuclepore filtration method and skin test
-------------------------------------------------------------------------------

### (1) A study in Kiyohara district, Bonotsu:

In this district, all 802 people examined in 1970 were proven to be microfilaria negative as a result of past DEC treatments. In 1979, a follow-up study was conducted by means of 60 µl blood smears using earlobe blood and 1 ml nuclepore membrane filtration using venous blood. No microfilaria was detected by either method. **Skin test** using FPT antigen (Tada, 1964), which was extracted from *Dirofilaria immitis*, was also employed to obtain information on sensitization to filariae. Positive rates by skin test in different age groups were 0% for 0-9 years, 5.3% for 10-19 years, 11.1% for 20-29 years, 35.3% for 30-39 years, 40.0% for 40-49 years, 42.6% for 50-59 years, 40.4% for 60-69 years, 54.8% for 70-79 years and 42.9% for 80 years and over. The positive rates increased gradually by age and reached a plateau after 40 years. A remarkable finding was that 56 children of age 0-9 years, who were born after treatments had eliminated microfilaremia were all negative (Fig. [8](#F8){ref-type="fig"}a, b). The skin test results from various endemic and non-endemic areas are compared in Fig. [9](#F9){ref-type="fig"}. Endemic areas show very high positive rates already at age 10 years, while Bonotsu shows a similar pattern to Nishinoura a non-endemic area, suggesting that the transmission of filariasis had been interrupted.

### (2) A study in Kuroshima island Yaeyama arehipelago, Okinawa:

Kuroshima had a population of 570 in 1967, but this decreased to 176 in 1980 for social and/or economic reasons. The microfilaria rates in 1967 and 1968 were 13.2% and 12.5%, respectively.

DEC treatment (6 tablets/day for 12 days) was given in 1968. The microfilaria rate by blood smear was 0.3% in 1976, which decreased to 0% in 1980. The nuclepore filtration method also detected no positive case in 1980.

The skin test results showed that the positive rate in the age group of 0-9 years declined steadily from 55.3% in 1967 to 11.3% in 1973 and to 0% in 1980, while adults of 30 years and older maintained high positive rates of 65-70%. These results suggested that children born after 1970 were not sensitized by filarial antigen, or that there had been no new infection over the previous 10 years.

2.6 Change in prevalence of chyluria after treatment
----------------------------------------------------

Between 1961 and 1965, 32,397 out-patients visited the 2nd Department of Internal Medicine, Kagoshima University Hospital, of whom 147 (0.45%) were chyluria cases. In the period of 1975-1979, there were 25 (0.09%) chyluria cases out of 27,037 out-patients. At Kagoshima Prefectural Oshima Hospital in Amami Oshima Island, where filariasis was highly endemic, chyluria patients in the same periods decreased from 176 (0.86% of 20,514 outpatients) to 30 (0.13% of 22,951 outpatients), indicating that DEC treatments contributed to the reduction of chyluria (Table [5](#T5){ref-type="table"}a, b). It is interesting to note that at the same Oshima Hospital, the number of chyluria patients did not decrease between 1981 and 1990 (Kimura E. This issue: 58-59)
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![The ancient Egyptian relief depicting elephantiasis at the Terrace of Queen Hatshepsut's temple.\
(a) Queen Hatshepsut's temple at EL-Deir Bahari, (b) The Egyptian Museum in Cairo, (c) A relief (replica) depicting bearers of merchandise and the ass to carry the princess of Punt (d) The princess of Punt with elephantiasis.](tmh-39-1-suppl_2-3-g001){#F1}

![A millennium-old picture scroll depicting elephantiasis.\
(a) Tokyo National Museum, (b) The "Diseases Picture Scroll" (left) and its wooden container (right), (c) & (d) A picture of a woman with elephantiasis on both legs.](tmh-39-1-suppl_2-3-g002){#F2}

![A millennium-old picture scroll ("Strange Diseases Picture Scroll") depicting elephantiasis and hydrocele.\
(a) Kyoto National Museum, (b) A lady with elephantiasis, (c) & (d) Hydocele (or elephantiasis of the scrotum) cases.](tmh-39-1-suppl_2-3-g003){#F3}

!["Big scrotum"(elephantiasis of the scrotum) drawn by Hokusai Katsushika in the Edo era.](tmh-39-1-suppl_2-3-g004){#F4}

![Change in microfilaria (Mf) counts after DEC treatment at different dosages (results of 5-year follow-up). Pre-treatment counts are regarded as 100%.](tmh-39-1-suppl_2-3-g005){#F5}

![Effects of 10 weekly treatments with DEC at 5 mg/kg, followed by 5 treatments at 6 mg/kg, on microfilaria (Mf) positive rate and the number of Mf (results of 10-year observation). Pre-treatment levels are regarded as 100%.](tmh-39-1-suppl_2-3-g006){#F6}

![The number of side reactions experienced by 181 people.](tmh-39-1-suppl_2-3-g007){#F7}

![Skin test results according to age group. (a) Age groups under 40 years, (b) Age groups of 40 years or more.](tmh-39-1-suppl_2-3-g008){#F8}

![Skin test results from various endemic and non-endemic areas.](tmh-39-1-suppl_2-3-g009){#F9}

###### 

Prevalence of filariasis in Kagoshima prefecture (1912-1961)

  \(a\) Results of examinations in the islands of Kagoshima                          
  ----------------------------------------------------------- ----- -------- ------- ------
  Amami-Oshima                                                58    15,206   2,976   19.6
  Mishima and Toshima                                         13    2,304    369     16.0
  Tanegashima and Yakushima                                   21    5,933    597     10.1
  Koshikijima                                                 11    1,788    267     14.9
  Nagashima                                                   9     838      128     15.3
  Total                                                       112   26,069   4,337   16.6

  \(b\) Results of examinations in the mainland of Kagoshima                         
  ------------------------------------------------------------ ---- -------- ------- ------
  South Satsuma                                                30   9,084    1,025   11.3
  Central                                                      9    793      102     12.9
  Northern                                                     15   2,504    293     11.7
  North Osumi                                                  1    97       0       0.0
  South Osumi                                                  12   1,881    209     11.1
  Total                                                        67   14,359   1,629   11.3

###### 

Side effects caused by Supatonin

  Study site (No. examined)   A (81)   B (27)   C (21)   D (8)   E (44)   Total (181)   \%
  --------------------------- -------- -------- -------- ------- -------- ------------- ------
  fever                       18       10       2        4       13       47            25.9
  shivering                   8        8        2        0       10       28            15.5
  lymphnode swelling          5        3        2        0       1        11            6.1
  scrotal swelling            2        1        1        0       1        5             2.8
  malaise                     27       14       9        7       25       82            45.3
  headache                    22       15       4        7       20       68            37.6
  dizziness                   9        4        1        2       2        18            9.9
  headache dull               15       7        2        4       11       39            21.5
  nausea                      7        2        3        1       4        17            9.4
  vomiting                    2        1        1        0       0        4             2.2
  anorexia                    11       4        3        2       11       31            17.1
  diarrhea                    4        6        3        3       8        24            13.2
  gurgle                      21       11       3        2       11       48            26.5
  abdomiral pain              10       2        1        0       7        20            11.0
  no reactions                33       4        7        0       8        52            28.7

###### 

Effects of time of blood collection on Mf detection rate and the number of Mf\*

  Hours of blood collection   18:00                           19:00   20:00   21:00   22:00   
  --------------------------- ------------------------------- ------- ------- ------- ------- --------
  A                           No. Mf positives                19      44      53      62      63
  B                           Mf positive rate 100 x (A/63)   30.1%   70.0%   84.1%   98.4%   100.0%
  C                           Total no. of Mf                 29      653     2437    3596    7410
  D                           Average no. of Mf (C/A)         1.5     14.8    46      58      117.6

\* 63 known Mf positives were examined.

###### 

Changes in microfilaria (Mf) positive rate in Kagoshima prefecture during the National Filariasis Control Program

  Year    No. examined   No. Mf positive   Mf Positive rate (%)
  ------- -------------- ----------------- ----------------------
  1962    135,557        8,968             6.6
  1963    167,604        6,597             3.9
  1964    99,864         4,498             4.5
  1965    81,503         2,918             3.6
  1966    61,969         1,958             3.2
  1967    68,446         1,186             1.7
  1968    61,116         755               1.2
  1969    66,102         345               0.5
  1970    18,118         134               0.7
  1971    11,645         91                0.8
  Total   771,924        27,450            3.6

###### 

Change in the number of chyluria patients among outpatients.

  \(a\) The 2nd Department of Internal Medicine, Kagoshima University Hospital                                                                                            
  ------------------------------------------------------------------------------ ------- ------- ------- ------- ------- -------- ------- ------- ------- ------- ------- --------
  No. of outpatients                                                             5,880   6,130   6,349   6,429   7,609   32,397   5,420   5,819   5,501   5,143   5,154   27,037
  No. of chyluria                                                                15      62      29      19      22      147      5       6       5       3       6       25
  Rate (%)                                                                       0.26    1.01    0.46    0.30    0.29    0.45     0.09    0.10    0.09    0.06    0.12    0.09

  \(b\) Kagoshima Prefectural Oshima Hospital                                                                                            
  --------------------------------------------- ------- ------- ------- ------- ------- -------- ------- ------- ------- ------- ------- --------
  No. of outpatients                            3,459   3,655   3,823   4,680   4,897   20,514   5,210   5,137   4,330   4,142   4,132   22,951
  No. of chyluria                               28      51      22      40      35      176      8       6       8       3       5       30
  Rate (%)                                      0.81    1.40    0.58    0.85    0.71    0.86     0.15    0.12    0.18    0.07    0.12    0.13
